|
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma |
|
|
|
Title: |
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma |
Author: |
Nowak, A.K. Cook, A.M. McDonnell, A.M. Millward, M.J. Creaney, J. Francis, R.J. Hasani, A. Segal, A. Musk, A.W. Turlach, B.A. McCoy, M.J. Robinson, B.W.S. Lake, R.A. |
Appeared in: |
Annals of oncology |
Paging: |
Volume 26 () nr. 12 pages 2483-2490 |
Year: |
2015 |
Contents: |
|
Publisher: |
European Society for Medical Oncology |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|